Peptides have the potential for targeting vaccines against pre-speci®ed epitopes on folded proteins. When polyclonal antibodies against native proteins are used to screen peptide libraries, most of the peptides isolated align to linear epitopes on the proteins. The mechanism of cross-reactivity is unclear; both structural mimicry by the peptide and induced ®t of the epitope may occur. The most effective peptide mimics of protein epitopes are likely to be those that best mimic both the chemistry and the structure of epitopes. Our goal in this work has been to establish a strategy for characterizing epitopes on a folded protein that are candidates for structural mimicry by peptides. We investigated the chemical and structural bases of peptide-protein cross-reactivity using phage-displayed peptide libraries in combination with computational structural analysis. Polyclonal antibodies against the well-characterized antigens, hen eggwhite lysozyme and worm myohemerythrin, were used to screen a panel of phage-displayed peptide libraries. Most of the selected peptide sequences aligned to linear epitopes on the corresponding protein; the critical binding sequence of each epitope was revealed from these alignments. The structures of the critical sequences as they occur in other non-homologous proteins were analyzed using the Sequery and Superpositional Structural Assignment computer programs. These allowed us to evaluate the extent of conformational preference inherent in each sequence independent of its protein context, and thus to predict the peptides most likely to have structural preferences that match their protein epitopes. Evidence for sequences having a clear structural bias emerged for several epitopes, and synthetic peptides representing three of these epitopes bound antibody with submicromolar af®nities. The strong preference for a type II b-turn predicted for one peptide was con®rmed by NMR and circular dichroism analyses. Our strategy for identifying conformationally biased epitope sequences provides a new approach to the design of epitope-targeted, peptide-based vaccines.
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Introduction
Antibody (Ab) responses against folded proteins include reactivities against linear and discontinuous epitopes. Alanine mutagenesis studies (Jin et al., 1992) and other work have shown that the reactivities against linear epitopes represent a small fraction of the Ab response compared to those against discontinuous ones. Thus, the linear epitopes identi®ed by mapping studies using synthetic peptides (Milton & Van Regenmortel, 1979; Atassi 1984; Geysen et al., 1987) and phage-displayed peptide libraries (Folgori et al., 1994; Yao et al., 1995; Bonnycastle et al., 1996) , though minor, are signi®-cant in that they are the sites that typically crossreact well with peptides. Since the idea of peptidebased vaccines was ®rst proposed (Lerner, 1982) , much effort has focused on identifying peptides that will elicit Abs that cross-react with pre-speci®ed sites on a target protein. Although a number of such peptides have been reported (Arnon et al., 1971; Francis et al., 1987; Hastings et al., 1990; Javaherian et al., 1990; Keller et al., 1993; WhiteScharf et al., 1993; van der Werf et al., 1994; Motti et al., 1994; Robinson et al., 1995; Lundkvist et al., 1996) , it remains dif®cult to predict the epitopes on folded proteins that will make effective targets for peptide-based vaccines. More often than not, Abs raised against peptides bind with high af®nity to the peptide, but only weakly to the folded protein from which they were derived (Jemmerson, 1987) .
The linear epitopes identi®ed by cross-reactivity with short peptides are characterized by de®ned structures of relatively high¯exibility (Tainer et al., 1984; Westhof et al., 1984) , surface accessibility (Atassi & Lee, 1978; Milton & Van Regenmortel, 1979) and hydrophilicity (Hopp & Woods, 1981) ; these features usually correspond to turns and loops in folded proteins (Westhof et al., 1984) . These parameters have been used with some success to predict the regions of proteins that will cross-react with peptides Pellequer et al., 1991) . Presumably, shape complementarity between an epitope and the antigenbinding site of an Ab is more readily induced in mobile accessible regions of a protein than in more rigid ones; however, as yet there are no structures of Abs in complex with linear epitopes available to support this. Evidence for an induced-®t binding mechanism for linear epitopes has been obtained by Getzoff et al. (1987) , who identi®ed the critical binding residues of several cross-reactive epitopes using peptides bearing single amino acid replacements. Several epitopes contained critical residues that were buried in the native protein, suggesting that the structure of these epitopes was altered upon binding Ab. Thus, epitope¯exibility has functional signi®cance in peptide cross-reactivity.
While epitope¯exibility is clearly involved in peptide cross-reactivity, the role of conformational bias has also been recognized (Dyson et al., 1988a) . Although most short peptides possess considerable conformational¯exibility in aqueous solution, sequences have been identi®ed that confer structural stability to a peptide, as assessed by nuclear magnetic resonance (NMR) and circular dichroism (CD) analyses (Dyson et al., 1988b) . Such sequences are expected to form largely the same structures in the context of a folded protein or a peptide, thereby allowing antigen cross-reactivity. In support of this, conformational preferences for turns and helices in solution have been demonstrated in a number of antigenic peptides (Dyson & Wright, 1995) . Structural elements that are present in peptides in solution have also been demonstrated in the corresponding folded protein (Wien et al., 1995) , and in peptide-Ab complexes (Tsang et al., 1992; Rini et al., 1993; Ghiara et al., 1994; Campbell et al., 1997) . The role of structural stability in peptide mimicry of protein epitopes is further illustrated by studies demonstrating improved crossreactivity Hoess et al., 1994) and the production of higher-af®nity, proteincross-reactive Abs (Arnon et al., 1971; Satterthwait et al., 1989; Zhong et al., 1994; Cuniasse et al., 1995) when disul®de and other covalent constraints are incorporated into peptides. Thus, both structural mimicry by a peptide and¯exibility of the corresponding epitope contribute to cross-reactivity and the production of cross-reactive Abs.
The computational strategy, Sequery, was developed as a statistical screen of the Protein Data Bank (PDB; Bernstein et al., 1977; Abola et al., 1987) , to determine whether an amino acid sequence, or sequence pattern, possesses a local conformational preference independent of its protein context. Sequery has been successfully applied to model protein-targeting motifs (Collawn et al., 1991; Chang et al., 1993) as con®rmed by NMR (Bansal & Gierasch, 1991; Eberle et al., 1991) , and to model loop structures for crystallographic ®tting (Parge et al., 1993) and homology modeling (Fisher et al., 1994) . We employed Sequery, and an accessory program, Superpositional Structural Assignment (SSA), to identify conformational preferences in linear epitope sequences that are known to cross-react with peptides. Peptides bearing these conformationally preferred epitope sequences are expected to mimic the epitope structure, thus facilitating recognition by anti-protein Abs. The crossreactive epitopes used for this analysis were identi®ed by screening a panel of phage-displayed peptide libraries with polyclonal Abs against the model proteins hen eggwhite lysozyme (HEL) and worm myohemerythrin (MHr). For several of the epitope sequences, structural preferences emerged that matched the structures of the corresponding epitopes on HEL or MHr. An epitope sequence bearing a strong Sequery-predicted bias for a type II b-turn was shown to have the same well-de®ned turn preference when analyzed as a free peptide in solution by NMR and CD spectroscopy. Moreover, synthetic peptides predicted to bear structurally biased sequences were shown to bind Ab with sub-micromolar af®nities. Thus, we have shown that short, cross-reactive sequences on linear epi-topes have conformational preferences that allow peptides to functionally mimic epitope structures. The ability to identify, from a set of cross-reactive epitopes, those that have the highest structural propensities, should prove valuable in the design of peptide-based vaccines.
Results
Cross-reactive peptides reveal linear epitopes on native HEL and MHr
To identify peptides that bind Abs against folded proteins, we screened a panel of linear and conformationally biased peptide libraries with polyclonal anti-HEL and anti-MHr Abs. The random peptides in the majority of the libraries were fused to the N terminus of the major coat protein pVIII of ®lamentous phage, whereas the peptides in two of the libraries were fused to the minor coat protein pIII. Three to four rounds of screening were performed on the library panel, and ®ve to 20 clones were analyzed from each of the phage pools showing high enrichment and/or strong ELISA signals. As shown in Table 1A and B, consensus sequences were revealed by aligning similar peptide sequences into consensus groups. Linear epitopes on HEL and MHr were subsequently identi®ed by aligning consensus sequences to the amino acid sequence of the corresponding antigen. From this, ®ve epitopes comprising the following sequences were identi®ed on each antigen: DVQ, DITASV, NAWV, RTPGS, and TQATNR on HEL, and KYSEV, PEPYV, WDESF, GLSAPVDA, and APNLA on MHr. Two``sub-epitopes'' were identi®ed for the KYSEV epitope; KYSE from the pVIII library screening and YSEV from the pIII library screening. This probably re¯ects small differences in the anti-MHr response, as the pIII and pVIII libraries were screened with anti-MHr Abs from different rabbits (see Materials and Methods) .
In a few cases, the alignment of a peptide to a single consensus group was not clear; either residue patterns common to two consensus groups were present, or the peptide had only two residues in common with a consensus group. Clone-againstclone competition ELISAs were performed to determine correct alignments; a peptide was assigned to a given consensus group if its corresponding phage clone could inhibit Ab binding to an immobilized clone whose displayed peptide aligned well to this group. The degree to which selected phage clones inhibited Ab-binding to representative immobilized phage is shown in Table 1A and B. This provided a functional assay for assigning peptides to a consensus group.
For peptides containing multiple cysteine residues, we investigated whether constraints imposed by disul®de bridging were required for Ab-binding. Reducing ELISAs were performed, in which binding to immobilized clones was assayed in the presence of 5 mM dithiothreitol (DTT), after reduction of disul®de bridges with 15 mM DTT.
The level of inhibition by DTT is shown in Table 1A and B. Peptides in the DVQ and KYSEV consensus groups were most dramatically affected by DTT reduction; binding of Ab was inhibited considerably for clones containing multiple cysteine residues. In both these groups, however, at least one strong-binding clone was derived from an unconstrained library, suggesting that the requirement for disul®de-bridging depends on the sequence of the peptide. Only the weak-binding clones in the DITASV group were affected, and little or no effect was seen on peptides in the PEPYV group. Thus, the presence of disul®de bonds can contribute to binding for many of the peptides, but is not an absolute requirement for cross-reactivity with any of the epitopes identi®ed.
To ensure that the cross-reactive peptides were not isolated by minor Ab reactivities against denatured or proteolyzed forms of the HEL and MHr antigens, competition ELISAs were performed using HEL and MHr in solution. Both antigens were in their native, folded form, as each of their electrophoretic mobilities corresponded to single, discrete bands on a non-denaturing polyacrylamide gel. Table 1A and B shows that binding to the majority of clones was strongly inhibited (575% inhibition) by their cognate antigen. Weak inhibition (less than 25%) was observed for a few clones, particularly those having relatively high af®nities. In these cases, the Abs may have bound more tightly to the phage clone than to cognate antigen. The alternative, that these clones were selected by Abs speci®c for the unfolded protein, is unlikely, since other clones in the same consensus group (and in the same assays) were inhibited by native antigen.
Binding of synthetic peptides to anti-HEL and anti-MHr Abs
To determine if free peptides behave similarly to the phage-displayed peptides, several peptides were synthesized and tested for their ability to bind Ab. Four biotinylated peptides, each derived from a tight-binding clone in a major consensus group, were synthesized as follows: Cys6-7 from the DVQ group; Cys5-1 from the DITASV group, X6-1 from the RTPGS group and X6-14 from the PEPYV group (Table 1A and B; see Materials and Methods for peptide sequences). All of the peptides were shown to bind strongly to Ab by direct ELISA and to inhibit binding of Ab to the corresponding clones in a dose-dependent manner (data not shown). Average equilibrium dissociation constants (K d values) were obtained for each of the four peptides using the KinExA automated immunoassay instrument (Sapidyne Instruments, Boise ID). The KinExA instrument is a computer-controlled¯ow spectro¯uorimeter designed to achieve the rapid separation and quanti®cation of uncomplexed Ab present in reaction mixtures of Ab, antigen, and Ab-antigen complexes (Blake et al., 1997) . As shown in Figure S1 of Supplementary Material. Taken together, the data indicate that the Abs bind with moderate af®nites to these peptides, whether they are displayed as pVIII-fusions on phage, or are free in solution.
Assignment of critical epitopes on HEL and MHr
Each epitope on HEL and MHr was mapped by matching conserved residues in each consensus sequence group to a sequence within the cognate protein antigen. The relative importance of each residue for cross-reactivity was further deduced from its pattern of amino acid replaceability within the consensus sequence group. Residues that were irreplaceable, or could only be conservatively replaced, were considered``critical binding residues''. These residues are likely to contribute signi®cantly to binding energy by interacting directly with the Ab combining site, and/or by contributing to the overall structure of the epitope . Based on this analysis, the critical binding sequences, or``critical epitopes'', for HEL and MHr are DVQ, DITXXV, NAW, RXPGS, KYSE (pVIII), YSEV (pIII), EPYV and WDXSF, in which X represents a non-critical residue in the sequence. Table 1A and B shows the critical sequences for the epitopes whose consensus groups contain at least four peptides. Figure 1 (a) and (b) shows the locations of the linear epitopes on the HEL and MHr structures, respectively. Each of the epitopes is well exposed on the surface of the protein, with the exception of NAW, which lies on the surface of HEL, but at the opening of the substrate-binding cleft. Most of the epitopes comprise turns or loops between regions of regular secondary structure. In HEL, the RTPGS 10 phage clones in solution. e Underlined and bold-faced amino acids, critical binding residues; boldfaced (but not underlined) amino acids align with the corresponding HEL or MHr sequence or with other peptides in the consensus group, but are not critical, as determined by incomplete conservation within the consensus group.
f Z, Non-aligning residues in peptides from the X30 libraries. g B, Residues not determined.
topes reside in regions of relatively high mobility and surface accessibility (data not shown; see Thornton et al., 1986) . Flexibility and accessibility are features typical of protein epitopes that crossreact with peptides (Westhof et al., 1984; Tainer et al., 1984; Thornton et al., 1986; Geysen et al., 1987) .
Evidence for structural mimicry of protein epitopes by peptides
The sequences of critical epitopes were analyzed in three phases to assess the structural basis for mimicry by the peptides. In the ®rst phase, the amino acid sequences of 493 non-redundant protein structures in the PDB (Hobohm et al., 1992 ; see Materials and Methods) were scanned for occurrences of all or part of each critical epitope sequence. Four-residue sequence patterns were used, each comprising three critical binding residues and one variable residue, since exact matches to more than three residues are rarely found in the PDB. Thus, for example, the critical epitope RXPGS was analyzed using the sequence patterns [R,K,H]XPG, XPGS and PGSX. Sequery provided a list of all sequence matches, or analogs, for each sequence pattern. The epitopes TQATNR on HEL and GLSAPVDA and APNLA on MHr were not included in the Sequery analysis, since only a few peptides aligned to each of these. At least one sequence pattern for each of the other epitopes yielded a substantial number of sequence analogs from the Sequery search. Sequence patterns yielding less than ten analogs were not considered to have given a suf®cient statistical sample, and thus were not analyzed further.
In the second phase of the analysis, the structure of each sequence analog was compared with that a Initial Ab concentrations were as follows: 20 nM anti-HEL for Cys5, 5 nM anti-HEL for Cys6-7, 50 nM anti-HEL for X6-1, and 100 nM anti-MHr for X6-14.
b The error bounds represent a 95% con®dence interval (similar to AE2 standard deviations) in the K d estimate, and are a function of best ®t error of the theoretical binding curve to the data.
of the corresponding four-residue sequence within the appropriate epitope on HEL or MHr. The program SSA compared these structures by superimposing their backbone atoms and calculating the root-mean-square deviation (RMSD) between the positions of corresponding atoms in the two backbones. The structure of a given analog was considered to closely resemble an epitope if the superpositional RMSD between the two backbones was 40.75 A Ê . A sequence pattern was considered to have a conformational preference for the epitope structure if at least 25% of the analogs superimposed well on the epitope.
Based on this analysis, conformational preferences matching the corresponding epitope structures were detected for the sequence patterns, DVQX, DITX, XPGS, and DXSF as shown in Table S1 in Supplementary Material. The frequency of analogs matching the structure of the corresponding epitopes is indicated in Table 3 ; those with the highest frequency of superposition are assumed to have the strongest preference for the epitope conformation. These analogs are shown superimposed on their corresponding epitopes in Figure 2 (a) to (d). In each case, conformational preference was highly dependent on the position of the variable residue, X, within the sequence pattern. For instance, nine of the 20 DVQX analogs superimposed well on the DVQA epitope in HEL, yet none of the XDVQ analogs superimposed well on the TDVQ site. This indicates that the conformation imposed by the critical binding sequence DVQ involves a fourth residue at its C terminus and not its N terminus. The fact that each critical sequence occurs in the same structure in a number of non-homologous proteins suggests that local conformation is de®ned by local interactions within these sequences, rather than by tertiary interactions with the rest of the protein. Cross-reactive peptides bearing these sequences are likely to mimic the structures of the corresponding protein epitopes. Sequence patterns for the remaining epitopes did not yield analogs that superimposed well on the epitope structures.
In the third phase of the structural analysis, SSA was used to classify the structures of each epitope segment and the corresponding sequence analogs as turn, helix, extended (b-strand) or irregular, based on their superposition with model tetrapeptides having ideal secondary structures. An overall conformational preference for each sequence pattern was assigned if at least 25% of the analogs possessed the same structure. These data are summarized in Table 3 for the DVQ, RXPGS, WDXSF and DITXXV epitopes. Both the DVQX and DXSF patterns have helical conformational preferences, and the XPGS pattern has a type II b-turn preference. The conformational preference of the DITX pattern was de®ned as irregular, since neither the DITASV epitope, nor any of its analogs, superimposed well on any of the model tetrapeptides. Yet, ®ve of the 20 DITX analogs superimpose well on DITA in HEL, and in all of these structures, the backbone of the aspartic acid is in an extended conformation, with the remainder of the sequence forming part of a turn (Figure 2(b) ). Hence, the conformational preference of all four sequence patterns is considered turn-like. Helical conformation- a Number of sequence analogs with structures that superimpose on the corresponding HEL or MHr epitope with an RMSD 40.75 A Ê divided by the total number of sequence analogs for a given sequence pattern. Sequence analogs from proteins whose crystal structures were not well-resolved (52.6 A Ê resolution) or whose backbones could not be superimposed due to missing atoms in the crystal structures, were not included in the analysis.
b An overall conformational preference was assigned to the sequence pattern if 525% of the analogs shared the same secondary structure. When this did not occur, the percentage of irregular structure is indicated.
c Surface accessibility (Kabsch & Sander, 1983) : buried, 0 to 40 A Ê 2 ; intermediate, 41 to 80 A Ê 2 ; exposed, >80 A Ê 2 .
al preferences were also observed for the sequence patterns NAWX and EXYV (see Table 3 ). Yet these analogs did not superimpose well on their corresponding epitopes, and hence, were not investigated further as candidates for structural mimicry. All of the epitope sequences that we analyzed were identi®ed by cross-reactivity with peptides; a number of these showed a structural propensity. As a comparison, we wanted to determine the extent to which randomly chosen sequences would also show a structural propensity. A set of sequence patterns was randomly generated, and Sequery was used to identify sequence analogs from the list of non-redundant protein structures in the PDB. Ten of the sequence patterns yielded analog sets containing ten or more matches, as shown in Table S2 of Supplementary Material. Next, a pseudo-epitope was randomly chosen from each analog set, with the only requirement being that it be surface-exposed within its protein structure. SSA was used to compare the structure of each pseudo-epitope with its corresponding sequence analogs, and to assign secondary structures, as was done with the Ab-selected epitope sequences shown in Table 3 . As with the Ab-selected sequence patterns, several of the randomly generated sequence patterns showed a clear propensity for a regular secondary structure. Furthermore, if the structure of a pseudo-epitope matched that of the overall structural propensity of the sequence pattern, a high proportion of the analogs also superimposed well on the pseudo-epitope. Thus, this analysis showed that the structural propensities of the epitopes we studied are similar to those of randomly chosen surface-exposed sites on proteins in general, and are not unique to peptidecross-reactive sequences. Importantly, analysis by Sequery in combination with SSA has allowed us to target, from a set of peptide-cross-reactive epitopes, those whose structures are more likely to be mimicked by peptides.
The molecular basis of conformational preferences
To understand the basis of locally induced structural preferences, we analyzed the inter-residue The epitope tetramers are shown in yellow, the sequence analogs are shown in magenta for the HEL epitopes, and in red for the MHr epitope. Hydrogen bonds are indicated in white. (a) DVQX analogs superimposed on the DVQA epitope; PDB codes for the proteins bearing the sequence analogs are 1pox, 1pea, 2dnj, 7rsa, 1cns, 1smn, 1ash, 1ukz and 1qpg. (b) DITX analogs superimposed on the DITA epitope; PDB codes, 3cla, 1dpb, 8cat, 1rcb and 1cpt. (c) XPGS analogs superimposed on the TPGS epitope; PDB codes, 1slt, 1arv, 1mhl, 1cdo, 1fuj, 1pya, 1qpg, 1hxn, 1abr, 1eft, 2dnj, 8acn and 1arb. (d) DXSF analogs superimposed on the DESF epitope; PDB codes, 1pvd, 1gsa, 1gpc, 2ctc and 3pmg.
interactions within each epitope and within the corresponding structural matches. These interactions are summarized in Table 3 , along with other relevant structural features. The epitopes and their analogs comprise turn-like conformations, which allow more stabilizing interactions within the tetramer than would occur in extended conformations. Speci®c hydrogen bonds appear to be important in stabilizing the structures of the DITASV, RTPGS, and WDESF epitopes and their analogs (Table 3 and Figure 2(b), (c) and (d) ). The DITASV epitope and all ®ve of its structural matches have a hydrogen bond between the O g of threonine and the O d1 of aspartic acid, as well as other hydrogen bonds; these interactions probably stabilize the helical-turn structure. Several of the hydrogen bonds present in the WDESF epitope are also seen in its structural matches. Finally, the hydrogen bond between the O g of serine and the carbonyl oxygen of threonine is present in the RTPGS epitope and in ten of the 13 XPGS analogs. Commonly, b-turns are stabilized by a hydrogen bond between the carbonyl oxygen at position 1 and the amide at position 4 of the turn (Venkatachalam, 1968) . Atypical hydrogen-bonding in the XPGS analogs resulted in several of them being classi®ed as irregular turns, since their structures are more open than classical type II b-turns. In addition to stabilization from hydrogen bonds, the type II b-turn preference suggested for the XPGS sequence pattern is promoted by proline and glycine, which often occur at positions 2 and 3, respectively, of type II turns (Wilmot & Thornton, 1988; Richardson & Richardson, 1990) . Proline produces a kink in the polypeptide chain at position 2, due to its ring closure, and glycine is favored in position 3 because it lacks a b-carbon and therefore does not sterically interfere with the carbonyl oxygen of proline. These interactions likely contribute to the stability of the protein epitopes and to preferred structures for the cross-reactive peptides.
TPGS has a type II turn conformational preference in solution
We predicted that peptides bearing conformationally biased sequences would have preferred structures in solution. To test this, the peptide Ac-TPGS-NH 2 was synthesized, and its structure was analyzed using NMR and CD spectroscopy. The TPGS sequence was selected for structural analysis over DVQA, DITA and DESF for several reasons: (i) the type II b-turn appeared to be a strong conformational propensity, with 39% of the XPGS sequence analogs possessing this structure; (ii) the TPGS turn in HEL and all of the XPGS analogs are stabilized by a hydrogen bond; and (iii) the peptides in the RXPGS consensus group were short and did not contain cysteine residues, suggesting that anking residues were not necessary for stabilization of structure. The TPGS sequence was synthesized as a blocked peptide in order to neutralize the termini and better mimic the natural state of this sequence within a protein or a longer peptide.
The structure of Ac-TPGS-NH 2 in aqueous solution was analyzed by 1 H NMR spectroscopy. Since the amino acid residues were unique, and sequential assignments followed unambiguously from spin system assignments, the proton resonances of Ac-TPGS-NH 2 were assigned directly from the DQF-COSY spectrum. Proton resonances are summarized in Table S3 of Supplementary Material. The trans conformation of the peptide was identi®ed by the presence of strong crosspeaks between Thr1 H a and Pro2 H d in the ROESY spectrum; no evidence for the cis conformation was found. The ROESY spectrum in Figure 3 shows a strong ROE between Pro2 H a and Gly3 H N . In addition, a medium ROE was observed between Gly3 H N and Ser4 H N (not shown), indicating a signi®cant population of type II b-turn (Wagner et al., 1986) . The weak connectivity between Pro2 H a and Ser4 H N , which is also expected for type II b-turns, was not observed; this may be due to overlap of the H a resonances of Pro2 and Ser4. The temperature coef®cient of Ser4 H N is À6.5 ppb/K, which is smaller than the temperature coef®cient observed for Thr1 H N and Gly3 H N , À9.7 and À9.3 ppb/K, respectively; this suggests that the Ser4 backbone amide proton participates in an intramolecular hydrogen bond. Structural calculations were performed on the unblocked TPGS peptide. An ensemble of 50 peptide structures was calcu- Cross-reactivity Between Peptides and Proteins lated using 17 ROE-based distance restraints and one hydrogen-bond distance restraint between Ser4 and Thr1, which was derived from the lowered Ser4 H N temperature coef®cient (see Table S4 , Supplementary Material). The distance restraint violations in the calculated structures were below 0.1 A Ê . The RMSD of all calculated structures to the average conformation was 0.61 A Ê for backbone atoms and 1.12 A Ê for all atoms. The backbone torsion angles of the average structure, f 2 À66 , c 2 138
and f 3 74 , c 3 3 correlate well with those of an ideal type II b-turn, which has torsion angles of f 2 À60
, c 2 120 and f 3 90 , c 3 0 (Richardson, 1981) . The backbone RMSD for the superposition of the calculated TPGS average structure and the TPGS epitope in HEL (residues 69 to 72) was 0.44 A Ê , indicating close structural similarity for the two backbones. A ball-and-stick model of the calculated average conformation is shown in Figure 4 , showing the interproton distances and the hydrogen bond between the serine amide and the threonine carbonyl oxygen. A hydrogen bond between the serine hydroxyl and the threonine carbonyl, as is seen in the TPGS epitope (Figure 2(c) ), was not detected in the NMR spectra.
CD analysis of Ac-TPGS-NH 2 was performed to corroborate the NMR ®ndings. The CD spectrum of Ac-TPGS-NH 2 in water, shown in Figure 5 , is highlighted by two minima at 200 nm and 223 nm. Deconvolution of the CD spectrum by convex constraint analysis (Perczel et al., 1991) yielded two pure component curves representing 55% (curve 1) and 35% (curve 2) of the peptide conformation. Curve 1 has a maximum at 203 nm characteristic of a type II b-turn conformation, whereas curve 2 has a minimum at 199 nm and was assigned as atypical or random secondary structure (Hollosi et al., 1987; Perczel et al., 1993) . Thus, the NMR and CD results for the Ac-TPGS-NH 2 peptide are consistent with a type II b-turn, as predicted by Sequery/SSA and observed in the HEL epitope.
Discussion
Peptide library screening in combination with computational and structural analyses identifies epitope sequences having inherent structural propensities
The goal of this work was to establish a means of identifying immunogenic sites on proteins that can be structurally mimicked by peptides. We characterized a set of linear epitopes on HEL and MHr based on their cross-reactivity with phagedisplayed peptides. The critical binding sequences within the epitopes were de®ned from the patterns of conserved residues within the selected peptides, and were assessed for their degree of intrinsic structural bias using the Sequery and SSA computer algorithms. Turn-like structures for the sequences DVQX, XPGS, DITX, and DXSF were conserved between each epitope and a number of non-homologous proteins, suggesting that these linear epitopes have inherent conformational preferences. Analysis of the structures of the epitopes and the matching sequence analogs showed similar hydrogen-bonding patterns that could potentially stabilize these conformations. A type-II b-turn preference was con®rmed for the RTPGS epitope by NMR and CD analysis of the synthetic peptide Ac-TPGS-NH 2 . Furthermore, synthetic peptides were made from selected clones from three of the consensus sequence groups predicted to have conformational preferences; these bound to Ab with submicromolar af®nities, and inhibited Ab binding to immobilized phage bearing the same sequence. Thus, we have identi®ed, from a set of linear epi- topes, those whose structures and binding activities are mimicked by peptides.
Sequery, in combination with SSA, provides a means of identifying short sequences that have structural propensities, based on the structural similarity of a given sequence in the context of a number of non-homologous proteins. The molecular basis of these propensities could be understood by analyzing the interactions within the sequences in each protein structure. Thus, in our analysis of the peptide-cross-reactive epitopes in HEL and MHr, the presence of stabilizing features, such as intra-epitope hydrogen bonds that were also present in the analog set, further strengthened our con®dence in a given epitope sequence having a structural propensity. Thus, the results of the Sequery, SSA and structural analyses were viewed together in determining epitope sequences that are likely to adopt de®ned conformations in the context of a peptide. We expect that these peptides will be more effective at eliciting Abs capable of recognizing the cognate antigen than peptides that do not mimic their epitope structures, and are in the process of testing this prediction.
Critical binding residues play a dual role in cross-reactivity; they impart structural stability, which allows recognition by Abs, and they provide energetically favorable binding contacts. Most likely, all peptides that cross-react with linear epitopes mimic the corresponding epitope structures to some degree. The structural biases we identi®ed appear to be conferred mainly by hydrogen bonding and, in one case, a proline-induced backbone constraint (Table 3 ). Yet, the residues involved in promoting a given structure are not necessarily suf®cient for recognition by Abs. In the case of the RTPGS epitope, although the TPGS sequence was important for structural mimicry, it was insuf®-cient for Ab recognition, as the synthetic peptide Ac-TPGS-NH 2 did not inhibit Ab binding to phage from the TPGS consensus group, even at a concentration of 50 mM free peptide (L.C. & J.K.S., unpublished data). Thus, a basic residue N-terminal to the TPGS sequence appears to be required for binding (as seen by the phage ELISAs in Table 1A ), but not for structure. In some cases, structural bias may require, or bene®t from, further stabilization by other residues, such as cysteine. This was apparent from the variation in requirements for disul®de bridging within the different consensus groups (Table 1A and B) . Additionally, residues other than critical binding residues can contribute to af®nity through increased contacts with Abs.
Polyclonal anti-protein Abs favor peptidemimics of linear epitopes
All of the peptides selected in our polyclonal Ab screenings aligned to linear epitopes on HEL and MHr. This was surprising, since antibodies against discontinuous epitopes predominate in anti-protein responses (Benjamin et al., 1984; Jin et al., 1992) , and peptide-mimics of discontinuous epitopes, or`m imotopes'', have been selected by others using polyclonal serum Abs (Folgori et al., 1994; Meola et al., 1995) , and monoclonal Abs against discontinuous epitopes (Balass et al., 1993; Felici et al., 1993; Stephen et al., 1995; Bonnycastle et al., 1996 ; L.C., J. Shen & J.K.S., unpublished data). The critical residues in mimotopes appear to be larger in number and more dispersed than in linear epitope mimics, and hence, they are likely to be present in smaller numbers in the libraries. This may explain why the clones that we select with monoclonal Abs against discontinuous epitopes are often weak binders (Bonnycastle et al., 1996) , which require optimization of residues anking the consensus sequences to obtain moderate binding af®nities (K. L. Brown, E. Leong & J.K.S., unpublished data). Our ultimate goal is to select peptides that not only cross-react with antiprotein Abs, but that also elicit protein-cross-reactive Abs; this is most likely to be successful if the af®nities of the cross-reactive peptides are comparable to those of the proteins. Our results indicate that peptide-mimics of linear epitopes dominate in af®nity-selections; thus, they may prove viable targets for peptide-based vaccine strategies.
Critical binding residues provide insight into the mechanism of Ab binding
Four of the ®ve MHr epitopes found in our study were identi®ed by Geysen et al. (1987) , who tested the reactivity of polyclonal anti-MHr sera against a panel of short, overlapping synthetic peptides representing the entire sequence of the antigen. Several of the most reactive peptides were remarkably similar to the linear epitopes found in our peptide-library screenings. Although the critical residues de®ned by Geysen et al. (1987) differed somewhat from our assignments, both studies revealed a requirement for aromatic residues in the cross-reactive peptides. Aromatic residues that could not be replaced by chemically similar amino acids were assumed to be directly involved in Ab binding . The side-chains of these critical aromatic residues are buried in the protein epitope and thus are locally inaccessible (see Table 3 and Getzoff et al., 1987) . To explain how Ab might interact with these inaccessible residues in the protein epitope, Getzoff et al. (1987) proposed an induced-®t binding mechanism, in which Ab initially contacts the solvent-accessible residues on the epitope, then induces a conformational change exposing the hydrophobic sidechain for binding. Such changes may be limited to local movements exposing a buried side-chain, or may involve more signi®cant backbone rearrangements.
Conformational changes of epitopes induced upon Ab binding are likely facilitated by their locations in¯exible regions of the protein. However, even those epitopes with high mobility values have well-de®ned structures, since they can be resolved crystallographically. Structural stability has been demonstrated for peptides that crossreact with linear epitopes, as shown here and by others (Dyson & Wright, 1995) . These ®ndings are consistent with a two-step binding mechanism, in which Abs initially recognize gross structural elements, followed by conformational adjustments that improve complementarity at the Ab/antigen interface (Tainer et al., 1984; Friedman et al., 1994) . Thus, structural bias can play a role in cross-reactivity with peptides, even when an induced-®t binding mechanism is involved.
Cross-reactivity can occur with a minimal number of shared residues
We and others have shown that peptides having only a few residues in common with a protein epitope can cross-react with that epitope. The idea that short peptides can cross-react with folded proteins has been challenged on the basis of crystallographic data (Laver et al., 1990) . X-ray crystal structures of Ab-protein complexes show 15 to 22 protein residues in contact with the combining site of an Ab (Davies et al., 1988; Braden & Poljak, 1995) , and thus short peptides seem unlikely to provide suf®cient contacts for binding. However, thermodynamic studies of Ab-protein interactions indicate that only ®ve or six of the large number of protein residues contacting the antigen combining site actually contribute to the energetics of binding (Novotny, 1991) . Moreover, the only Ab-protein complexes whose crystal structures have been solved involve discontinuous epitopes, in which the critical binding residues are spread over two or more segments of the protein.
Peptides generally cross-react with linear epitopes on folded proteins, where the critical residues are located on a continuous segment of the protein (although additional residues on neighboring segments may make non-critical contacts). Thus, although the critical binding residues identi®ed for the HEL and MHr epitopes probably represent only a subset of the contact residues in the protein epitope, they make major contributions to the binding energetics.
Cross-reactivity requires that the Ab combining site has shape complementarity with both the linear epitope and the peptide It has been suggested that all epitopes are discontinuous to some extent, and that short peptides that cross-react with native antigen only mimic part of the epitope . For this to occur, the critical binding residues must be located on a single segment of the protein that protrudes somewhat, so that these residues will make extensive contacts with the Ab combining site. The locations of most of the linear epitopes identi®ed here correspond to regions of high mobility and accessibility. Such regions tend to have high protrusion indices Thornton et al., 1986) , which allow Ab to make central, critical contacts with a continuous segment of the protein. Abs that bind to such sites, as well as to cross-reactive peptides, must have unique binding sites that will accomodate the epitopes on both antigens.
The structure of the Ab combining site is determined to a large degree by the surface formed from its six hypervariable loops (L1-L3, H1-H3). Chothia & Lesk (1987) identi®ed a set of backbone frameworks, or canonical structures, which describe much of the structural variation in ®ve of the six hypervariable loops (all except H3). The combinations of canonical structures used by Abs against a variety of antigens including proteins, peptides, carbohydrates and haptens has been analyzed (Vargas-Madrazo et al., 1995) . This study showed that anti-peptide Abs use a restricted set of canonical structure combinations as compared to anti-protein Abs; this restriction is re¯ected in variable-gene usage (Lara-Ochoa et al., 1996) . This group and others Wilson et al., 1995; MacCallum et al., 1996) have characterized the combining sites of anti-peptide Abs as grooved; this shape allows extensive interaction with a small number of peptide residues. In contrast, the antigen binding site of Abs speci®c for discontinuous epitopes is¯attened, to accommodate a larger surface area, and the residues of these epitopes are, on average, less buried within the Ab combining site than those of bound peptides.
The cross-reactivity observed here between peptides and linear epitopes is likely due to Abs whose combining sites resemble those of antipeptide Abs. Evidence supporting this comes from crystallographic studies of two monoclonal Abs in complex with peptides (Tormo et al., 1994; Wien et al., 1995) . Both Abs were raised against native or heat-inactivated virions, and recognize intact viral particles; they also cross-react with peptides, and their combining sites resemble those of anti-peptide Abs. Moreover, the linear epitopes they recognize protrude (Wien et al., 1995) , or are predicted to protrude (Tormo et al., 1994) from the viral coat, which would allow them to be buried in the Ab combining site much like the peptides. Thus, in these cases, cross-reactivity is associated with a grooved,`a nti-peptide ± Ab-like'' combining site.
Future studies
An understanding of the molecular basis of protein-peptide cross-reactivity is critical in the design of vaccines that use peptides to target epitopes on folded proteins. We describe a means of identifying immunodominant, linear epitopes on protein antigens that are likely to be structurally mimicked by peptides. These peptides, when used as immunogens in conventional immunization strategies, may not elicit strong reactivity against a targeted site, since the combining-site structure of the anti-peptide Abs elicited will typically be groove-like. As mentioned, even though the combining site of such Abs may be centrally con®gured to make favorable contacts with a protruding linear epitope, their ridged periphery may not ®t with regions surrounding the epitope. Abs having a different combining-site structure from those elicited against the peptide may be required for cross-reactivity with the targeted site. Several prime-and-boost strategies, involving immunizations with whole protein and peptide, have successfully enhanced protein cross-reactivity (Emini et al., 1983; Girard et al., 1995; Davis et al., 1997) . These strategies involve priming with one antigen and boosting with the other, so as to enhance the production of cross-reactive Abs. These immunization strategies, using peptides identi®ed in this study, should provide a substantial test of the viability of epitope-targeted vaccines. Ultimately, our ability to target Ab responses to pre-selected epitopes will depend on our understanding of all aspects of cross-reactivity, including the structures of the peptide, the targeted site and the Abs involved in the desired cross-reaction. This knowledge should allow us to develop a rational means for producing in vivo Abs having predetermined antigen speci®city.
Materials and Methods

Materials
All of the IgGs and antisera used were derived from rabbits. MHr protein and anti-MHr Abs that had been af®nity puri®ed on MHr ) were provided by H. Alexander (Univerisity of Missouri-Columbia); anti-MHr serum was a gift from S. J. Rodda (Chiron Corporation, Melbourne). Anti-HEL immune sera and IgG that had been af®nity puri®ed on HEL, as well as puri®ed HEL were provided by I. Kumagai (Tohoku University, Sendai). The pIII-displayed X6 library (Scott & Smith, 1990) and the Cys2-6 pVIII libraries were provided by G.P. Smith (University of Missouri-Columbia); the 15mer pVIII library (Nishi et al., 1993) was provided by H. Saya (University of Kumamoto, School of Medicine). The remaining pVIII libraries, with the exception of AH (see below), are described by Bonnycastle et al. (1996) . Biotinylation of Abs, isolation of IgG from immune sera, preparation of the anti-phage antisera, and the sources of other reagents are as described (Bonnycastle et al., 1996) .
The TPGS peptide (Ac-TPGS-NH 2 ) was synthesized by UBC Biotechnology, NAPS Unit (Vancouver). The biotinylated peptides Cys6-7, Cys5-1, X6-1 and X6-14 were synthesized and puri®ed by reversed phase HPLC by The Alberta Peptide Institute (Edmonton). The Cys6-7 and Cys5-1 peptides were subsequently oxidized and repuri®ed to isolate only disul®de-bridged peptides. The sequences of the peptides are as follows: Cys6-7, NH 2 -VNIACNPTDIQCLIRLPAE-bioK-norL-K-CONH 2 ; Cys5-1, NH 2 -NQPSCQDITACLTPQ-bioK-norL-K-CONH 2 ; X6-1, NH 2 -SKTPGAAAE-bioK-norL-C-CONH 2 ; and X6-14, NH 2 -QEPYVLAAEGD-bioK-norL-K-CONH 2 , in which bioK is biotinylated lysine, and norL is norleucine. Cy3-conjugated Af®Pure goat-anti-rabbit IgG was purchased from Jackson ImmunoResearch (West Grove, PA). Biotin-labeled bovine serum albumin (BSA) was purchased from Sigma Chemical Co. (St. Louis, MO). Polymethylmethacrylate (PMMA) beads (100 mm) were from Sa Åpidyne Instruments Inc. (Boise, ID).
The panel of epitope libraries
The peptides in phage-display libraries are fused to the N terminus of either the minor coat protein pIII or the major coat protein pVIII. The panel of peptide libraries comprised two pIII-displayed libraries, X6 and X15, and 13 pVIII-displayed libraries, X5CX2CX5 (Cys2), X5CX3CX4 (Cys3), X4CX4CX4 (Cys4), X4CX5CX4 (Cys5), X4CX6CX4 (Cys6), XCX6CX (LX6), XCX8CX (LX8), X8CX8, XCCX3CX5C (aCT), X6, X15, X30 and AH (see below); Xn represents n randomized residues (X), and C represents a ®xed cysteine. The random peptides of the pIII libraries are preceeded by the N-terminal sequence ADGA and followed by GGAGAE. The random peptides in all of the pVIII-display libraries begin at the N terminus and are followed by a variety of sequences: PAEGDD (Cys libraries); GGIEGRGP (aCT), GGPAEG (one of the two LX6 libraries), AAEGDD (the remaining libraries). The AH library was designed by T. J. Mason (Melbourne), J. A. Tainer (The Scripps Research Institute, La Jolla) and H. M. Geysen (GlaxoWellcome, Research Triangle Park), and constructed by L. L. C. Bonnycastle (Simon Fraser University) as described (Bonnycastle et al., 1996) . The peptide insert has the sequence EQLAKSEEQLAKXXEQXXKXXXK-XEQLAKSEEQLAX, which is predicted to have a-helical propensity.
Screening the panel of libraries with anti-HEL and anti-MHr Abs
The screening of pVIII libraries with anti-HEL and anti-MHR Abs (screening 1) has been described (Bonnycastle et al., 1996) . Caprylic acid-puri®ed Abs were used throughout four rounds of anti-MHr selection, and for rounds 1, 3 and 4 of the anti-HEL selection, with af®nity-puri®ed anti-HEL Abs being used in round 2. The pIII and the AH libraries were screened with antiMHr in two separate experiments; af®nity-puri®ed antiMHr Abs were used to screen the two pIII libraries (screening 2), and caprylic acid-puri®ed, anti-MHr Abs were used to screen the AH library (screening 3) essentially as described (Bonnycastle et al., 1996) . Brie¯y, $10 10 to 10 12 virions from each library were af®nity-selected over three or four rounds of panning on biotinylated Abs that had been immobilized on avidin or streptavidin-coated microwells or Petri plates; enrichment for Ab-binding phage was assessed by titering the phage output after each round of panning. Phage were ampli®ed in Escherichia coli cells, and ampli®ed phage pools from the third and fourth rounds were tested for Ab binding by ELISA. Individual clones were isolated from pools showing positive enrichment and/or ELISA signals. These clones were sequenced in the region of the peptide insert, and tested for binding by ELISA. Clones were sequenced using the method of either Haas & Smith (1993) or Sanger et al. (1977) . Pooled phage from the Cys2, Cys3 and AH libraries showed only weak enrichment and ELISA signals after three rounds, and were not studied further.
Cross-reactivity Between Peptides and Proteins
ELISAs
Following a previously described protocol (Bonnycastle et al., 1996) , $2 Â 10 10 virions were immobilized either by direct adsorption to microwells by overnight incubation at 4 C, or by incubation for one hour at room temperature in wells that had been coated overnight with 1 mg of anti-phage Ab. Wells containing bound phage were blocked with BSA or non-fat milk, then 60 nM biotinylated anti-HEL Ab or 100 nM biotinylated anti-MHr Ab was added for 3.5 hours at room temperature. The plates were washed after each step using an automated microplate washer. Bound Ab was detected using horseradish peroxidase-avidin complexes and 2,2 H -azino-bis(3-ethylbenzthiazoline-6) sulfonic acid as substrate. Absorbance values were measured at 405 nm minus 490 nm. The ELISA signal for fd-tet (pIII) or f88.4 (pVIII) phage, without a peptide insert was subtracted from those of the isolated phage clones (f88, 0.017 to 0.042 absorbance unit; fd-tet, 0.046 to 0.087 absorbance unit). The results are reported only for clones having an A 405-490 5 0.100 absorbance unit above that of the fd-tet or f88 phage. For competition ELISAs, biotinylated Abs (100 nM) were pre-incubated with 5 mM native HEL or MHr, or with $2 Â 10 10 virions, for two hours at room temperature prior to incubation with immobilized phage. Only a few of the clones from the pIII libraries were tested for competition with MHr, because the Abs used to screen the pIII libraries had been af®nity-puri®ed on native MHr.
KinExA immunoassay
PMMA beads were coated with peptide as follows: 200 mg of beads were suspended in Tris-buffered saline (TBS, 50 mM Tris-HCl (pH 7.4), 150 mM NaCl) containing 0.1 mg of biotinylated BSA and gently rotated for one hour at 37 C. The beads were washed ®ve times with TBS, then rotated with 0.1 mg of streptavidin in TBS for one hour at 37 C. The beads were washed ten times with TBS, then rotated with 10 mg of biotinylated peptide in TBS for one hour at 37 C, and stored at 4 C. Prior to use, 10 mg of biotin was added to the coated beads, which were then rotated for one hour at 37 C and suspended in 30 ml of TBS/10 mg/ml BSA.
The KinExA assay for K d determination is described by detail by Blake et al. (1997) , and is described here brie¯y. For each peptide, the optimal Ab concentration was chosen to give a¯uorescent signal of approximately one volt when 100 ml was passed through a KinExA¯ow cell containing peptide-coated beads. Ab at this concentration was incubated with varying concentrations of biotinylated peptide in TBS/10 mg/ml BSA/0 1% (v/v) Tween and allowed to come to equilibrium at room temperature for a minimum of two hours. The amount of uncomplexed Ab in the equilibrium reaction was quanti®ed by capture on peptide-coated beads, followed by detection using¯uorescently labeled anti-rabbit Abs. A fraction of the uncomplexed Ab in each equilibrium reaction was captured by¯owing 100 ml of the reaction over peptide-coated beads, followed by a wash with 350 ml of TBS/0.1% Tween. The amount of primary Ab bound to the beads was quanti®ed by¯owing 1 ml of Cy3-conjugated goat anti-rabbit Ab (1 mg/ml) over the beads, followed by a wash (1.625 ml). All reagents were passed over the beads in the¯ow cell at a rate of 0.250 ml/min. Fluorescence of the bead-bound Cy3-conjugate in the¯ow cell was measured over the course of the reaction, and the difference in the signal before and after addition of Cy3 was taken as a measure of beadbound primary Ab. This signal should be directly proportional to the amount of uncomplexed Ab in the equilibrium reaction mixture. Reactions were run in duplicate, and¯uorescent signals were plotted as a function of peptide concentration.
Data analysis was performed using the software provided by the manufacturer (Sa Åpidyne Instruments, Inc. 
Combining this equation with the equation for free antibody at equilibrium resulted in a theory of signal as a function of K d , Ab t , Ag t , Sig100% and Sig0%. The software used this theory to ®nd the values of K d , Ab t , Sig100%, and Sig0% which minimized the squared error between the theory and the measured signals. The 95% con®dence interval was found by varying the K d parameter and re-optimizing the other variables at each point. Thus, the analysis ®nds the range over which the K d or Ab t maintain ®t to the data points.
Sequery
A set of amino acid sequence patterns was determined for each epitope, based on the critical binding residues identi®ed by alignment of peptides with the HEL and MHr epitopes. The computer program Sequery was developed by L.A.K., M. E. Pique, E. D. Getzoff & J. A. Tainer at The Scripps Research Institute (as a successor to Searchwild, which is described by Collawn et al., 1990) . Sequery was used to search the largest non-redundant set of PDB sequences (493 with no more than 25% sequence identity; Hobohm et al., 1992 were found, and the sequence and position of the analogs and residues¯anking the analogs. The structure of each sequence analog was then assessed using SSA (developed by P.C.S. & L.A.K.).
SSA
The SSA algorithm was used to (i) assess the degree of structural similarity between epitopes on HEL and MHr and the corresponding sequence analogs found by Sequery, and (ii) assign secondary structures to the sequence analogs. SSA uses a least-squares ®tting algorithm to superimpose the backbone atoms of an analog in question onto a template, then calculates the backbone RMSD as a measure of structural similarity of the two. For the analysis of the HEL and MHr epitopes, tetrapeptide templates were derived from the structural coordinates of each epitope identi®ed by peptide mapping. The sequence analogs were then superimposed on the corresponding epitope template; those having a RMSD of 40.75 A Ê were considered to match the epitope structure.
For the assignment of secondary structures to the sequence analogs, each analog was compared with a set of tetrapeptides comprising ideal structures of an a-helix, a b-strand, and the most prevalent b-turns (type I, type II, type II H , type II H , and type VIII). These ideal structures were created using the Biopolymer module in InsightII (Molecular Simulations, Inc., San Diego). InsightII values for the backbone f and c angles were used for the a-helix and b-strand constructs, and the average f and c values from a statistical analysis of b-turns, as reported by Hutchinson & Thornton (1994) , were used to construct each turn segment. Sequence analogs that superimposed onto a model secondary structure with a RMSD of 40.75 A Ê were assigned to that structure; however, some analogs matched well with both the helical and b-turn models. To distinguish between these, the RMSD between the helical model and the analog was also measured by shifting one residue forward or backward on the protein structure from which the analog was derived; if either of these was also 40.75 A Ê , the analog was assigned as a helix. Analogs were assigned as``irregular'' if none of the model peptides superimposed with an RMSD 40.75 A Ê .
Four-residue peptides were used in the secondarystructure assignments for several reasons: (i) b-turns are inherently four residues long; (ii) the periodicity of a-helices is approximately four residues; (iii) b-strands alternate twice within four residues; and (iv) most of the work with Sequery uses tetrapeptides, since exact matches to longer sequences are not likely to be found in the PDB. Prior to this study, SSA was validated by comparing its automated assignments to those made by detailed visual molecular graphics analyses for 158 tetrapeptide segments from a broad range of proteins (P.C.S. & L.A.K., unpublished data). This test resulted in a fourstate (a-helix, b-strand, b-turn and irregular) agreement between SSA and visual assignments of 81.6%. A second comparison was performed on 533 tetrapeptide segments from two proteins representing all b, and a and b structural folds, and resulted in a four-state agreement of 85.9% over 533 segments. An upper bound of 0.75 A Ê for backbone atom RMSD was found to be optimal for automated assignment of secondary structure.
The Sequery and SSA software were written in the C programming language, and will be provided to other research groups upon request to L.A.K.
NMR spectroscopy and the structure calculation of the TPGS peptide
The sample of Ac-TPGS-NH 2 (7 mM in 0.5 ml) was prepared by diluting a stock solution of the peptide with aqueous buffer containing 0.1 M sodium chloride, 0.04 M sodium phosphate, 1% (w/v) sodium azide and 5% 2 H 2 O (pH 5.5). NMR spectra were acquired on a Bruker AMX600 spectrometer (Bruker, Karlsruhe, Germany). Two-dimensional phase-sensitive DQF-COSY (Rance et al., 1983) and ROESY (Bothner-By et al., 1984; Bax & Davis, 1985) spectra were acquired at 283 K using TPPI (Red®eld & Kunz, 1975) . The sweep widths were 6666 Hz in both dimensions, and 512 t 1 increments were collected in 2048 complex data points with 32 transients. The spin-lock pulse for the ROESY spectrum had a strength of 6024 Hz and a duration of 300 ms. Water suppression was achieved using the WATERGATE technique (Piotto et al., 1992; Sklena Âr et al., 1993) in the ROESY spectrum, and selective irradiation of the water frequency during the recycling delay in the DQF-COSY spectrum. All NMR data were processed with the XWIN-NMR 1.2 program (Bruker). The data were apodized by 90 shifted quadratic sinebell windows functions, zero-®lled in both dimensions and transformed to 2000 Â 2000 matrices with a postacquisition treatment to suppress the residual water peak in the ROESY spectrum. An automatic base-line correction was applied to the ROESY spectrum before integrating the cross-peaks with XWIN-NMR. All chemical shifts were referenced to internal 4,4-dimethyl-4-silapentane-1-sulfonate.
Temperature coef®cients for the amide resonances were obtained by recording one-dimensional spectra between 283 and 303 K in steps of 5 K. The amide chemical shift was plotted as a function of temperature and the plot was analyzed by linear regression to extract the slope.
The ROESY cross-peak volumes were converted to distance restraints and calibrated to Pro2 H b1 -H b2 (1.8 A Ê ) using the procedure described by Hyberts et al. (1992) . The upper distance bounds were adjusted for pseudoatoms by adding 1.5 A Ê for any methyl group. For restraints involving only one of the non-stereospeci®cally assigned methylene protons, 1.7 A Ê were added to the upper distance limit. The structure calculations were performed with the unblocked TPGS peptide (i.e. the Nterminal acetyl group and the C-terminal amide were replaced with amide and carbonyl groups, respectively). The restraints to Thr1 H N were imposed on the pseudoatom of the N-terminal amino group, H N* , with no pseudo-atom correction. The structural ensemble of TPGS was calculated with the DGII program of Insight II 95.0 (Biosym/MSI, San Diego, CA).
CD spectroscopy of the TPGS peptide
The CD spectrum of Ac-TPGS-NH 2 was obtained at 278 K on a Jasco J710 spectropolarimeter (Japan Spectroscopic Co., Ltd, Tokyo). The peptide was dissolved in water and diluted to a concentration of 1 mM. The measurements were performed in a quartz cell of 0.1 cm pathlength. The CD spectrum is the average of 30 consecutive scans from 180 to 260 nm, recorded with a bandwidth of 0.5 nm, a time constant of 0.25 second and a scan rate of 20 nm/min. Following baseline correction, the observed ellipticities were converted to molar ellipticities. The CD spectrum was deconvo-luted using the convex constraint algorithm of Perczel et al. (1992) .
